Please assess the completion status of the following clinical trial:

Trial Title: Short-course Antibiotic Treatment in Gram-positive Cocci Infective Endocarditis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Definite IE, according to modified ESC 2015 criteria, caused by gram-positive cocci (staphylococci, streptococci and enterococci), including native, prosthetic valve IE and cardiac device-related IE.~* 18 years old or older.~* Patients treated for at least 10 days of appropriate parenteral antibiotic therapy overall (according to guidelines and microbiology sensitivity testing), and at least 7 days of parenteral antibiotic therapy after valve surgery when indicated.~* Absence of fever, microbiological or analytical findings suggesting persistent infection at randomization.~* Absence of locally uncontrolled infection signs (abscess, pseudoaneurysm, fistula, enlarging vegetation) at randomization, confirmed by recent transesophageal echocardiography (performed within 48 h of randomization).~* Women of childbearing potential who will agree to the use of effective contraceptive methods while on antibiotic treatment.~Exclusion Criteria:~* Patients who have received appropriate parenteral antibiotic therapy for infective endocarditis for more than 12 days.~* Patients not suitable to be discharged after 10 days of conventional treatment, due to clinical reasons (sequels of stroke that prevent discharge, progressive renal failure, hepatic failure).~* Patients receiving chemotherapy or immunosuppressive therapy.~* Pregnant or breastfeeding women.~* Need of prolonged antibiotic therapy due to spondylodiscitis or other septic complication.~* Absence of patient's ability or commitment to continue follow-up after being discharged from hospital.~* Inability to give informed consent to participation.~* Cognitive impairment or lack of language skills needed to complete the questionnaires.~* Patients who meet urgent cardiac surgery ESC criteria but are considered inoperable due to high surgical risk.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Short course (Type: EXPERIMENTAL): Patients allocated to this group will receive a short course of antibiotic therapy for 2 weeks.
- Standard course (Type: ACTIVE_COMPARATOR): Those patients allocated to continue with standard parenteral treatment will maintain the same antibiotic treatment for 4 to 6 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).